Rani Therapeutics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN JOSE, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (Nasdaq:RANI) (Rani Therapeutics or Rani), a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics…
